Bernard Lam
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Multi-platform reassessment of human mitochondrial DNA methylation reveals signals consistent with technical artifacts.
Journal: bioRxiv : the preprint server for biology
Published: June 29, 2026
Detection and classification of lymphoma from cell-free methylome data.
Journal: NPJ precision oncology
Published: August 26, 2025
Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma.
Journal: JCO precision oncology
Published: July 09, 2025
Elucidating divergent biology in uterine carcinosarcoma.
Journal: Translational oncology
Published: February 27, 2025
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer.
Journal: Clinical colorectal cancer
Published: February 28, 2024
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.
Journal: Cancer discovery
Published: April 18, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 17, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2023
Coronavirus disease 2019 (COVID-19) outbreak on an in-patient medical unit associated with unrecognized exposures in common areas-Epidemiological and whole-genome sequencing investigation.
Journal: Infection control and hospital epidemiology
Published: March 13, 2023
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 17, 2022
Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 13, 2022
Last Updated: 09/26/2026